SCHEMBL31744751

SCHEMBL31744751

Cc1[nH]c2ccc(O)cc2c1Oc1ccccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
HTR1D P28221 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTR7 P34969 1/20 0.47
HTR3A P46098 1/20 0.47
HTR6 P50406 1/20 0.47
GAA P10253 3/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
CASP6 P55212 1/20 0.41
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744599 0.86 HSD17B10 (0.45) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL4772243 0.72 GAA (0.54) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL31744773 0.72 HTR2C (0.45) HSD17B10CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL31744790 0.71 HPGD (0.41) HSD17B10TDP1CYP1A2CYP2C9MAPK1
SCHEMBL31744930 0.70 TDP1 (0.44) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
Chlorobenzene SCHEMBL5800449 0.69 GAA (0.45) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL4377509 0.69 KDM4E (0.58) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL28709106 0.69 TDP1 (0.57) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL22802317 0.69 TDP1 (0.43) HSD17B10TDP1CYP1A2CYP3A4CYP2D6
SCHEMBL31744811 0.69 HTR7 (0.57) HSD17B10TDP1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 HSD17B10 781/4885TDP1 3408/4885CYP1A2 3820/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 HSD17B10 781/4885TDP1 3408/4885CYP1A2 3820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.